Laxogol (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350, the primary osmotic agent in Laxogol, retains water within the intestinal lumen, creating an osmotic gradient that softens stool and expands its volume. The added electrolytes help maintain fluid balance while the increased intraluminal water stimulates gentle peristalsis, facilitating bowel movements without stimulating secretions.

The appropriate dose of Laxogol is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of constipation, and the specific bowel‑preparation protocol required. Dosing instructions are individualized and should be followed exactly as written on the prescription label.

Safety data for Laxogol in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the medication.

To order Laxogol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Laxogol contains macrogol 3350 together with balanced electrolytes, which can provide a more controlled fluid and electrolyte profile compared with plain polyethylene glycol formulations. This combination may reduce the risk of electrolyte imbalance in some patients, while offering similar efficacy in stool softening and bowel cleansing.

Laxogol should be stored at ambient temperature, below 25 °C, in its original packaging. The container should be kept tightly closed, protected from moisture, direct sunlight and excessive heat to maintain product stability and potency.

Laxogol is taken orally, typically as a powder that is dissolved in water or another suitable liquid according to the prescriber’s instructions. The solution is consumed at the time and dosage specified on the prescription, and patients should follow any additional guidance regarding fluid intake.

The most serious risks include severe electrolyte disturbances such as hyperkalemia or hyponatremia, significant dehydration, and allergic reactions that may present as rash, swelling or anaphylaxis. If any of these symptoms occur, medical attention should be sought immediately.

Laxogol should be avoided in individuals with a known complete intestinal obstruction, severe renal impairment, or hypersensitivity to any of its ingredients. It is also contraindicated in patients for whom electrolyte balance cannot be monitored, and use should be carefully considered in the elderly and in those with chronic dehydration.